ABSTRACT Susceptibility to spontaneous testicular germ cell tumors (TGCTs), a common cancer affecting young men, shows unusual genetic complexity. Despite remarkable progress in the genetics analysis of susceptibility to many cancers, TGCT susceptibility genes have not yet been identified. Various mutations that are inherited as Mendelian traits in laboratory mice affect susceptibility to spontaneous TGCTs on the 129/Sv inbred genetic background. We compared the frequency of spontaneous TGCTs in single-and doublemutant mice to identify combinations that show evidence of enhancer or suppressor effects. The lowerthan-expected TGCT frequencies in mice with partial deficiencies of TRP53 and MGF-SLJ and in 129.MOLFChr19 (M19) consomic mice that were heterozygous for the A y mutation suggest that either these genes complement each other to restore normal functionality in TGCT stem cells or together these genes activate mechanisms that suppress incipient TGCTs. By contrast, the higher-than-expected TGCT frequencies in Mgf Sl-J -M19 compound heterozygous mice suggest that these mutations exacerbate each other's effects. Together, these results provide clues to the genetic and molecular basis for susceptibility to TGCTs in mice and perhaps in humans.
T ESTICULAR germ cell tumors (TGCTs) are the characteristics of TGCTs in these strains suggest that 129/Sv mice are an important model for pediatric germ most common cancer affecting young men. The incidence of TGCTs has doubled within the last 50 years, cell tumors that occur in humans (Stevens 1967; Jiang and Nadeau 2001; Lam and Nadeau 2003) . These tupredominately in Eastern Europe, indicating that environmental factors affect susceptibility (Buetow 1995) .
mors originate during fetal development and are composed of various cell types and tissues at different stages Genetics also contributes to TGCT susceptibility, with an increased risk of 8-to 10-fold among brothers and of differentiation. In both humans and mice, males develop pediatric germ cell tumors before puberty and 4-fold among sons of affected individuals (Forman et al. 1992; Lindelof and Eklund 2001) . Despite its prevathese tumors are classified histologically as nonseminomas. lence, little is known about the genetic control of TGCT susceptibility. Mapping studies have revealed many weak In mice, primordial germ cells (PGCs) are the earliest recognizable precursors of gametes and arise outside the autosomal linkages (Leahy et al. 1995; Bishop 1998) gonads (Molyneaux et al. 2001) . During embryogenesis, but only one significant linkage at Xq27 (Rapley et al. PGCs are first identified around embryonic day 7 (E7) 2000). To date, TGCT susceptibility genes have not yet at the primitive streak. The PGCs leave the yolk sac, been identified in humans. Linkage studies have been migrate through the dorsal mesentery of the gut, and difficult in part because of the limited number of multiarrive at the genital ridges by E11.5. As the PGCs migrate generational pedigrees with sufficient numbers of aftoward the genital ridges, they proliferate, with the numfected individuals. The 129/Sv inbred strain of laboraber increasing from ‫04ف‬ at E7 to ‫0002ف‬ at E11.5 when tory mice is an important model for unraveling the they arrive at the genital ridges. At E13.5, PGCs enter complexity of the genetic control of susceptibility and G 1 mitotic arrest and remain arrested until a few days resistance to TGCTs (Stevens and Hummel 1957) .
after birth (Donovan et al. 1998) . This period from Linkages and genes discovered in studies of these mice E11.5 to E13.5 is thought to be when TGCT developcould be used to guide studies in humans. ment begins. It has been hypothesized that PGCs fail TGCTs are rare in most inbred mouse strains and to enter G 1 mitotic arrest and continue to divide into occur spontaneously at a rate of 1-5% in the 129/Sv pluripotent stem cells called embryonal carcinoma cells inbred strains (Stevens and Hummel 1957) . Various that in turn become tumors composed of various cells and tissue types (Jiang and Nadeau 2001) . Several mutations that are inherited as Mendelian 1 netic background to exert their influence, demonstramales (Matin et al. 1999) . Heterosomic animals, which have only one copy of the MOLF-derived chromosome ting that these mutant genes act together with 129/Svderived genes to control susceptibility.
19, have a tumor incidence of 20%, and only 2-3% of the affected animals have bilateral tumors (Matin et al. The Steel (Sl) and White-spotting (W) mutants were first identified as coat color variants (Silver 1995 ). Sl 1999 Youngren et al. 2003) . A y is a mutation with dominant effects at the Agouti mutants result from molecular lesions in the mast cell growth factor (Mgf ) gene (Copeland et al. 1990 ) and W (a) locus on mouse chromosome 2 (Michaud et al. 1994) . The A y mutation results from an ‫-071ف‬kb delemutants from lesions in the kit oncogene, which encodes the c-kit tyrosine kinase cell surface receptor for the tion of the entire coding region of the Raly gene, which is proximal to the Agouti gene. This deletion places MGF ligand (Chabot et al. 1988) . Mice with mutations in these genes are defective in melanogenesis, gametothe coding region of Agouti under the transcriptional control of the Raly promoter, resulting in ubiquitous genesis, and hematopoiesis. The MGF-KIT signaling pathway is required for PGC survival and proliferation expression of the agouti gene product (Michaud et al. 1993 (Michaud et al. , 1994 Khrebtukova et al. 1999) . The A y phenoduring germline development (Dolci et al. 1991) .
Stevens transferred several Sl and W mutations onto type is associated with obesity, diabetes, and yellow coat color (Bultman et al. 1992) . A y mice also show increased the 129/Sv inbred strain to study tumorigenesis and found that only Sl and Sl J alleles cause a significant susceptibility to pulmonary and mammary gland tumors in females, induced skin tumors in both sexes, and hepaincrease in the frequency of TGCTs, whereas other alleles of Sl and W mutants did not affect susceptibility tomas in males (Stevens 1967 Sl-J is a spontaneous mutation that results from an ‫-046ف‬kb detenth the incidence of testicular germ cell tumors as the wild-type littermates (Stevens 1967) . letion that includes the Mgf gene (Bedell et al. 1996) . Homozygous Mgf Sl-J 
/Mgf
Sl-J mice are PGC deficient and Testicular cancer is a complex trait that may require as many as six independently segregating genes with embryonic lethal (Stevens 1967) . Heterozygous 129/ Sv-Mgf Sl-J /ϩ males have a tumor incidence more than additive and recessive effects (Stevens 1967) . The low frequency of spontaneous TGCTs in the 129/Sv inbred double (12-14%) the rate in their wild-type controls (5%; Stevens 1967) .
strain and the multigenic basis of the cancer together make it difficult to dissect the genetic control of susceptiTrp53 is a tumor suppressor gene that arrests cells to allow proper repair of DNA damage (Kastan et al.
bility of TGCTs. We used single gene mutations that are inherited as Mendelian traits to gain clues to the 1991). To study the role of TRP53 in tumorigenesis, a null mutation was created by homologous recombinanature of genes and pathways that affect TGCT susceptibility. The various mutations on the 129 genetic backtion in mouse embryonic stem (ES) cells (Donehower et al. 1992; Jacks et al. 1994) . Mice homozygous for the ground increase or decrease penetrance perhaps by activating novel pathways involved in tumorigenesis. The null allele appear normal but are prone to a variety of tumors, with lymphomas being the most common interaction of these Mendelian traits provides a unique opportunity to study TGCT development. In other (Donehower et al. 1992; Jacks et al. 1994) . The spectrum of tumors varies among TRP53-deficient mice on model systems, interactions between different pairs of genes have provided unique insights into developdifferent genetic backgrounds (Donehower et al. 1995) .
Loss of TRP53 appears to accelerate existing tumor premental pathways and cancer susceptibility (Moore et al. 1990; Oca Luna et al. 1995; Lamoreux et al. 2001 ; disposition in a background-dependent manner. In a mixed C57BL/6 and 129/Sv genetic background, only
Montes de Parant and Lozano 2003). We therefore tested interactions between pairs of TGCT susceptibility 9% of the TRP53-deficient mice develop testicular tumors, whereas on a pure 129/Sv genetic background, genes to evaluate their effect on tumor frequencies, laterality of the tumors, and parental effects to reveal 35% of the TRP53-deficient mice develop testicular tumors (Donehower et al. 1995) . more about the molecular and developmental pathways leading to tumorigenesis. A genome scan suggested that at least one gene on chromosome 19 of the MOLF/Ei inbred strain dramatically increases susceptibility to TGCTs (Collin et al. MATERIALS AND METHODS 1996) . 129.MOLF-Chr19 is a chromosome substitution strain (CSS), also known as a consomic strain, in which (Matin et al. 1999 crosses that were not previously tested. tionally large numbers of mice (Stevens 1967 ). We
Harvey et al. (1993) (Table 1A) .
TAGCGTTGG-3Ј; and X6.5, 5Ј-ACAGCGTGGTGGTACCT TAT-3Ј. Primers X7 and Neo19 amplify a 600-bp fragment with histological assessments showed that TGCTs rarely escape discovery, we made a 129/Sv-A y congenic strain and then detection (Matin et al. 1999; Youngren et al. 2003) .
transferred the A y mutation onto the 129.MOLF-Chr19 et al. 2003) were used in hetero-0.5), which represents an ‫-3ف‬fold, but not significant, reduction. The results obtained were not statistically zygous state to localize the region on MOLF-Chr19 that interacted with Mgf Sl-J to increase susceptibility to bilatsignificant probably because of the modest number of mice that were surveyed (N ϩ/ϩ ϭ 40; N Ay/ϩ ϭ 50).
eral tumors. A2 congenic mice have the proximal and the middle segment of MOLF-Chr19, whereas C2 conDouble-mutant interaction tests: Double-mutant mice were used to test for interactions between TGCT suscepgenic mice have the distal and the overlapping middle segment (with A2) of MOLF-Chr19. Parental effects betibility genes. We evaluated tumor frequency, tumor laterality, and parental effects in the double mutants.
tween the reciprocal A2/ϩ congenic crosses were not significant ( 2 ϭ 0.04; P Ͼ 0.5). The tumor frequency Mgf Sl-J and M19 double heterozygote: The doubleheterozygous mutants of the interaction test between in the pooled data for the double-heterozygous mutants A2/ϩ Mgf Sl-J /ϩ was 30% and these tumors were mainly Mgf Sl-J /ϩ and M19 revealed a higher-than-expected TGCT susceptibility (Table 2 ). There was no evidence unilateral (Table 3A) . In contrast, a modest parental effect was detected in of parental effects between the reciprocal crosses ( 2 ϭ 0.83; P Ͼ 0.1); the data for the two crosses were therefore the interaction cross between C2/ϩ and Mgf Sl-J /ϩ mice ( 2 ϭ 4.0; P Ͻ 0.025). A total of 97 double-heterozygous pooled. The control M19/ϩ ϩ/ϩ heterozygote littermates had a TGCT frequency of 32%, which was not mutants of parental crosses between C2 females ϫ Mgf Sl-J /ϩ males were examined and 10% of the doublesignificantly different from the 33% frequency that was found in the control test (Table 2) . If M19 and Mgf Sl-J heterozygous mutants developed TGCTs, of which only 2% were bilateral tumors (Table 3B ). In the reciprocal acted additively, the expected tumor frequency in the double-heterozygous mutants would be 45% [ϭ 33%
cross of Mgf Sl-J /ϩ females ϫ C2 males, 20% of 89 doubleheterozygous mutants developed TGCTs, of which only (M19/ϩ) ϩ 12% (Mgf Sl-J /ϩ)]. The observed TGCT frequency of 57% in the 215 double-heterozygous mutants 3% were bilateral tumors (Table 3C ). Double-heterozygous mutants from both congenic crosses had low tumor was significantly higher than expected ( 2 ϭ 9.7; P Ͻ 0.005). The increase in TGCT frequency resulted largely frequencies and, importantly, rarely developed bilateral tumors. It appears that Mgf Sl-J did not interact separately from an increase in the frequency of bilateral tumors, In the pooled The homosomic-congenic mutant had the expected high tumor frequency with an affected rate in the data of 75 double-heterozygous mutants, only 7% developed a TGCT (Table 5 ). The double-heterozygous mupooled data of 92% (Table 4) , which was not significantly different from the expected additive frequency tants had a tumor frequency fourfold lower than expected ( 2 ϭ 13.6; P Ͻ 0.001), which suggests that partial of 94% ( 2 ϭ 0.4; P Ͼ 0.5). The M19/M19 ϩ/ϩ littermates had a TGCT frequency of 80%, which was not deficiency of the tumor suppressor gene Trp53 and heterozygosity for the Mgf Sl-J deletion suppressed developsignificantly different from the expected tumor frequency (Matin et al. 1999 (Stevens 1967 ) but also causes a 25% reduction of TGCT incidence in the 129.MOLF-Chr19 CSS.
and at least two genes on chromosome 19 (one proximal and one distal) interacted to significantly increase the incidence of TGCTs. The increased frequency over the DISCUSSION expected additive tumor frequency results from an increased incidence of bilateral tumors. Congenic strains The low incidence of spontaneous TGCTs in the that dissect the MOLF-Chr19 into two regions, proximal 129/Sv inbred strain makes it difficult to study the geand distal, were crossed to the Mgf Sl-J /ϩ mutants. We netic control of TGCT susceptibility in these mice. In were, however, unable to localize the region on MOLFthis article, Mendelian mutations that are known to Chr19 that interacted with Mgf Sl-J to increase susceptibilindividually increase or decrease the frequency of ity to bilateral tumors. Heterozygous-congenic mutants TGCTs were used to test interactions as a way to learn showed that neither the proximal nor the distal end more about the pathways that control TGCT susceptiof the MOLF-Chr19 alone increased the incidence of bility.
bilateral tumors. These data complement the analysis The pairwise gene interaction tests showed that sevof the panel of congenic strains to characterize TGCT eral mutant genes enhanced or suppressed the developsusceptibility genes in the 129.MOLF-Chr19 CSS (Youngment of TGCTs. The M19/ϩ Mgf Sl-J /ϩ compound hetren et al. 2003) . A survey of TGCT frequencies in this erozygotes had a 27% increase in TGCT frequency over panel of congenic strains suggests that several genes on the expected additive rate. This increase resulted pri-MOLF-Chr19 affect TGCT susceptibility in both additive marily from an unexpectedly high frequency of bilateral and epistatic manners and act as enhancers or supprestumors. In contrast, an interaction between Mgf Sl-J and sors. The various congenic strains with only one segment Trp53 suppressed the development of TGCTs by about of MOLF-Chr19 did not have the high TGCT frequency fourfold in double heterozygotes, lowering the affected similar to the 129.MOLF-Chr19 CSS, whereas doublerate from the expected 26% to 7%, which is similar to congenic strains with both the proximal and distal end the background rate of the 129/Sv strain. The A y mutaof MOLF-Chr19, but missing the small middle segment, tion also suppressed the TGCT frequency in the 129. resulted in a TGCT frequency similar to that of MOLF-Chr19 CSS.
129.MOLF-Chr19 CSS (Youngren et al. 2003) . The douTraditionally, mutations that increase susceptibility to ble-congenic strain showed epitasis between TGCT suscancers have been studied to learn more about the ceptibility genes on MOLF-Chr19. The increased TGCT mechanisms that promote tumorigenesis. In this study, frequency in Mgf Sl-J /ϩ M19/ϩ mice may result from we discovered two pairs of interacting genes that supan interaction between Mgf Sl-J and an interacting set of pressed development of TGCTs and another pair of genes rather than from the individual component genes genes that enhanced susceptibility. These suppressors and enhancers may provide an important way to moduon chromosome 19. The increased susceptibility to bilat- (26) 65 (68) eral tumors may therefore require at least three factors: between E7.5 and E13 (Manova and Bachvarova 1991) to inhibit TRP53 function in PGC proliferation Mgf Sl-J , together with the proximal and distal portions of MOLF-Chr19. Interestingly, the homosomic-congenic (Abrahamson et al. 1995) . The Kit W-v mutants lack MGF-KIT signals and therefore cannot inhibit TRP53, leading mutants Mgf Sl-J /ϩ M19/M19 did not have an increased susceptibility to bilateral tumors, suggesting that the to apoptosis of PGC and sterility. Jordan et al. (1999) demonstrated that double mutants deficient in Trp53 interaction observed in the double heterozygous mutants is complex and perhaps involves a dosage effect.
and Kit rescued sterility defects because apoptosis of male germ cells is Trp53 dependent but apoptosis of Suppressors of TGCT susceptibility: The interaction crosses revealed two new models to suppress TGCT susmelanocyte and mast cells is regulated by a Trp53-independent pathway. This experiment explains how fertility ceptibility. Traditionally, genes that promote tumorigenesis are identified, with the ultimate goal of supcan be restored in mutants that lack the functions of KIT and MGF, but it does not readily explain the suppressing or preventing tumor formation by studying the mechanisms of tumorigenesis. Tumor suppression in pression of TGCT development in the double heterozygous mutants Mgf Trp53 mediates apoptosis and cell cycle arrest at the ment of TGCTs. Additional experiments are needed to learn more G 1 /S stage (Lee et al. 1994) , whereas the signaling pathway of the MGF-KIT prevents apoptosis and promotes about the mechanisms that suppress the development of TGCTs, such as immunohistochemistry to determine cell division and growth of melanocytes, mast cells, and germ cells (Dolci et al. 1991) . In a cell culture system, the localization of Trp53 within the testis of single-and double-mutant mice, measuring the levels of Trp53, and MGF inhibits Trp53-mediated apoptosis and differentiation, but not G 1 /S cell cycle arrest (Abrahamson et determining whether the interactions altered downstream or upstream the Trp53-mediated apoptosis or al. 1995). Most studies that examine the relationship between KIT/MGF signaling and TRP53 involve cell DNA repair pathway. From in vitro experiments, it does not seem likely that the MGF-KIT signaling pathway culture systems (Abrahamson et al. 1995; Matsui et al. 2000) , whereas Jordan et al. (1999) : Previous studies showed that A y mice have a greatly increased susceptibility to many different types of tumors MGF, are defective in melanogenesis, gametogenesis, and hematopoiesis. Although the phenotypes of most (Wolff et al. 1986; Wolff 1987) . However, 129/Sv male mice that are heterozygous for the A y mutation showed of the Kit and Sl mutants are similar, Stevens (1967) found contrasting results for several Kit and Sl alleles a 10-fold reduction in TGCTs (Stevens 1967) . The mechanism for this TGCT suppression was not pursued on the 129/Sv inbred background: Sl alleles (Sl and Sl J ) developed TGCTs more than twice as often as did the and Steven's congenic strain was lost many years ago. To verify findings of Stevens (1967) , we created a wild-type littermates, whereas none of the Kit mutants showed an increased susceptibility of TGCTs. In a sepanew 129-A y congenic strain. 129/Sv mice normally develop TGCTs at a rate of 1-5%; Stevens therefore rate study, the Kit W-v mutant was crossed to Trp53-deficient mutants to study the role of Trp53 in regulating needed to examine a large number of males to find the 10-fold reduction. To detect a stronger effect with a cell death in the absence of MGF-KIT signaling ( Jordan et al. 1999) . The double mutants that were deficient in smaller number of mice, we crossed A y congenic mice to a strain that has a high TGCT incidence, 129.MOLF-TRP53 function did not increase the survival of melanocyte and mast cells, but showed instead an increased Chr19 (Matin et al. 1999) . The M19/M19 strain of mice has a TGCT incidence of 80% (Matin et al. 1999 ) and number of germ cells and restored fertility ( Jordan et al. 1999 ). Normally, MGF-KIT signals are induced therefore serves as an excellent strain to test for TGCT suppression with A y . We found that the A y mutation does 1999). Raly functions in preimplantation development and its deletion accounts for the embryonic lethality indeed suppress TGCT formation and could serve a key role in understanding TGCTs and tumorigenesis in associated with the A y mutation (Duhl et al. 1994 ). Another gene located in the deletion between Raly's progeneral.
Although the suppressive effect of A y on TGCTs is moter and agouti that could account for TGCT suppression is eIF2s2. eIF2s2 is a eukaryotic translation initiation exciting, little is known about the ways in which this mutation affects tumorigenesis. Because the A y phenofactor involved in protein synthesis. Phosphorylation and dephosphorylation of eIF2s2 modulates protein type results from a large deletion upstream of agouti, two explanations for suppression are possible. The first translation (Lodish et al. 2000) . Further studies involving engineered mutations are being pursued to identify is that the ubiquitous overexpression of agouti, because of the A y mutation, results in TGCT suppression as a the gene near A y that suppresses TGCT susceptibility. Implications for TGCTs in humans: Because of the consequence of this unique expression pattern involving the melanocortin receptor signaling pathway. Anprevalence of testicular cancer, an international effort is underway to identify susceptibility genes in humans other explanation for suppression is the deletion of Raly or other genes between Raly and agouti found in the (Bishop 1998). However, lack of multigenerational pedigrees with several affected individuals has made the 170-kb region upstream of agouti. The first model suggests that TGCT suppression may be linked to the ubiqsearch difficult. Family studies typically have limited power to detect linkage for complex traits; nevertheless, uitous expression of agouti. Agouti is normally expressed during development, in neonatal skin, and in numerous weak linkages have been identified (Bishop 1998; Lindelof and Eklund 2001) . This raises the possithe testis (Yen et al. 1994) and is responsible for the wild-type coat color seen in mice (Silvers 1979) . Agouti bility that additional linkages are yet to be discovered. Utilization of our mouse models provides an opportuexpression results in the switching of eumelanin to phaeomelanin production by inhibition of ␣-melanonity to control the genetics involved, thereby increasing the power of linkage studies. Approaches in the mouse cyte-stimulating hormone due to antagonism of melanocortin receptor 1 (Bultman et al. 1992; Lu et al. 1994;  and in humans will complement the search for genes involved in the initiation and progression of TGCTs. Cone et al. 1996) . However, in A y mutants, ectopic agouti expression interferes with this switching pattern by pre- nin production. This results in the uniform yellow coat associated with the mutation (Cone et al. 1996) .
When expressed ubiquitously, it is possible that the (Michaud et al. 1993) . 
